These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 9819044

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Recombinant activated factor VII as a universal haemostatic agent.
    Hedner U.
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S147-52. PubMed ID: 9819047
    [Abstract] [Full Text] [Related]

  • 3. Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
    Santagostino E, Morfini M, Rocino A, Baudo F, Scaraggi FA, Gringeri A.
    Thromb Haemost; 2001 Oct; 86(4):954-8. PubMed ID: 11686352
    [Abstract] [Full Text] [Related]

  • 4. Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients.
    Brandsborg S, Sørensen B, Poulsen LH, Ingerslev J.
    Blood Coagul Fibrinolysis; 2006 Jun; 17(4):241-9. PubMed ID: 16651865
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
    Brady KM, Easley RB, Tobias JD.
    Paediatr Anaesth; 2006 Oct; 16(10):1042-6. PubMed ID: 16972833
    [Abstract] [Full Text] [Related]

  • 9. The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency.
    Huang WY, Kruskall MS, Bauer KA, Uhl L, Shaz BH.
    Transfusion; 2004 Nov; 44(11):1562-6. PubMed ID: 15504160
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Recombinant activated factor VII: treating postoperative hemorrhage in cardiac surgery.
    Bishop CV, Renwick WE, Hogan C, Haeusler M, Tuckfield A, Tatoulis J.
    Ann Thorac Surg; 2006 Mar; 81(3):875-9. PubMed ID: 16488687
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
    Meili EO, Dazzi H, von Felten A.
    Schweiz Med Wochenschr; 1995 Mar 04; 125(9):405-11. PubMed ID: 7892567
    [Abstract] [Full Text] [Related]

  • 16. Safety, efficacy and cost-effectiveness of home therapy with recombinant activated factor VII in a patient with severe haemophilia A and an anti-factor VIII inhibitor.
    Stewart AJ, Hanley JP, Ludlam CA.
    Blood Coagul Fibrinolysis; 1998 Mar 04; 9 Suppl 1():S93-5. PubMed ID: 9819036
    [Abstract] [Full Text] [Related]

  • 17. Clinical experience with activated factor VII: focus on safety aspects.
    Roberts HR.
    Blood Coagul Fibrinolysis; 1998 Mar 04; 9 Suppl 1():S115-8. PubMed ID: 9819041
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Immunological aspects of recombinant factor VIIa (rFVIIa) in clinical use.
    Nicolaisen EM, Hansen LL, Poulsen F, Glazer S, Hedner U.
    Thromb Haemost; 1996 Aug 04; 76(2):200-4. PubMed ID: 8865531
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.